Pulmonary Rehabilitation for Post-COVID-19.

IF 3.3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Cardiopulmonary Rehabilitation and Prevention Pub Date : 2023-11-01 Epub Date: 2023-08-04 DOI:10.1097/HCR.0000000000000813

Jafar Aljazeeri, Rayyan Almusally, Yijin Wert, Mostafa Abdelhalim, Cathleen Klinger, Navitha Ramesh, Taj Rahman

{"title":"Pulmonary Rehabilitation for Post-COVID-19.","authors":"Jafar Aljazeeri, Rayyan Almusally, Yijin Wert, Mostafa Abdelhalim, Cathleen Klinger, Navitha Ramesh, Taj Rahman","doi":"10.1097/HCR.0000000000000813","DOIUrl":null,"url":null,"abstract":"Purpose: Patients with COVID-19 often report persistent respiratory symptoms. Limited data exist on how to mitigate long-term sequelae of exercise intolerance and dyspnea. We aimed to study the role of pulmonary rehabilitation (PR) in patients with post-COVID-19.Methods: This was an observational study. Consecutive patients with post-COVID-19, admitted to three separate outpatient PR programs, were enrolled. The program consisted of 8-12 wk of PR sessions (3 times/wk). Data were gathered at the initial visit and discharge. The primary outcome was the change in the 6-min walk test (6MWT) distance. Secondary outcomes included the Shortness of Breath Questionnaire (SOBQ), modified Borg dyspnea scale, Patient Health Questionnaire-9 (PHQ-9), and Lung Information Needs Questionnaire (LINQ).Results: A total of 56 patients completed the PR program (age 62.8 ± 14.7 yr, 57% were men). At baseline, the mean 6MWT was 313.3 ± 193.8 m. On average, the 6MWT improved by 84.3 m after PR ( P < .0001). Apart from the modified Borg dyspnea scale, there was improvement across secondary outcomes: SOBQ (-16.9 points), PHQ-9 (-2.6 points), and LINQ (-4.2 points); all P < .05.Conclusion: Pulmonary rehabilitation showed a promising positive effect on patients with with post-COVID-19. It improved exercise capacity, perception of dyspnea, depressive symptoms, and patient knowledge needed to manage their lung disease. Pulmonary rehabilitation should be considered for post-COVID-19 patients.","PeriodicalId":15192,"journal":{"name":"Journal of Cardiopulmonary Rehabilitation and Prevention","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiopulmonary Rehabilitation and Prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HCR.0000000000000813","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Patients with COVID-19 often report persistent respiratory symptoms. Limited data exist on how to mitigate long-term sequelae of exercise intolerance and dyspnea. We aimed to study the role of pulmonary rehabilitation (PR) in patients with post-COVID-19.

Methods: This was an observational study. Consecutive patients with post-COVID-19, admitted to three separate outpatient PR programs, were enrolled. The program consisted of 8-12 wk of PR sessions (3 times/wk). Data were gathered at the initial visit and discharge. The primary outcome was the change in the 6-min walk test (6MWT) distance. Secondary outcomes included the Shortness of Breath Questionnaire (SOBQ), modified Borg dyspnea scale, Patient Health Questionnaire-9 (PHQ-9), and Lung Information Needs Questionnaire (LINQ).

Results: A total of 56 patients completed the PR program (age 62.8 ± 14.7 yr, 57% were men). At baseline, the mean 6MWT was 313.3 ± 193.8 m. On average, the 6MWT improved by 84.3 m after PR ( P < .0001). Apart from the modified Borg dyspnea scale, there was improvement across secondary outcomes: SOBQ (-16.9 points), PHQ-9 (-2.6 points), and LINQ (-4.2 points); all P < .05.

Conclusion: Pulmonary rehabilitation showed a promising positive effect on patients with with post-COVID-19. It improved exercise capacity, perception of dyspnea, depressive symptoms, and patient knowledge needed to manage their lung disease. Pulmonary rehabilitation should be considered for post-COVID-19 patients.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

COVID-19后肺部康复。

目的：新冠肺炎患者经常报告持续的呼吸道症状。关于如何减轻运动不耐受和呼吸困难的长期后遗症的数据有限。我们旨在研究肺康复（PR）在COVID-19后患者中的作用。方法：这是一项观察性研究。连续三名新冠肺炎后患者被纳入三个单独的门诊PR项目。该项目包括8-12周的PR会议（3次/周）。在初次就诊和出院时收集数据。主要结果是6分钟步行测试（6MWT）距离的变化。次要结果包括呼吸急促问卷（SOBQ）、改良博格呼吸困难量表、患者健康问卷-9（PHQ-9）和肺部信息需求问卷（LINQ）。结果：共有56名患者完成了PR项目（年龄62.8±14.7岁，57%为男性）。基线时，平均6MWT为313.3±193.8 m。PR后6MWT平均改善84.3 m（P<.0001）。除了改良Borg呼吸困难量表外，次要结果也有所改善：SOBQ（-16.9分）、PHQ-9（-2.6分）和LINQ（-4.2分）；结论：肺康复对COVID-19后患者具有良好的积极作用。它改善了运动能力、对呼吸困难、抑郁症状的感知，以及控制肺部疾病所需的患者知识。COVID-19后患者应考虑肺部康复。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Cardiopulmonary Rehabilitation and Prevention 医学-心血管系统

CiteScore

5.40

自引率

34.20%

发文量

164

审稿时长

6-12 weeks

期刊介绍： JCRP was the first, and remains the only, professional journal dedicated to improving multidisciplinary clinical practice and expanding research evidence specific to both cardiovascular and pulmonary rehabilitation. This includes exercise testing and prescription, behavioral medicine, and cardiopulmonary risk factor management. In 2007, JCRP expanded its scope to include primary prevention of cardiovascular and pulmonary diseases. JCRP publishes scientific and clinical peer-reviewed Original Investigations, Reviews, and Brief or Case Reports focused on the causes, prevention, and treatment of individuals with cardiovascular or pulmonary diseases in both a print and online-only format. Editorial features include Editorials, Invited Commentaries, Literature Updates, and Clinically-relevant Topical Updates. JCRP is the official Journal of the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation.